Nagaraj S. Nagathihalli

发表

Tobacco Carcinogen-Induced Production of GM-CSF Activates CREB to Promote Pancreatic Cancer.

N. Merchant, Jason A. Castellanos, M. VanSaun, 2018, Cancer research.

Signal Transducer and Activator of Transcription 3, Mediated Remodeling of the Tumor Microenvironment Results in Enhanced Tumor Drug Delivery in a Mouse Model of Pancreatic Cancer.

Alex J. Walsh, Michelle L. Reyzer, X. Chen, 2015, Gastroenterology.

Pancreatic stellate cell secreted IL-6 stimulates STAT3 dependent invasiveness of pancreatic intraepithelial neoplasia and cancer cells

N. Merchant, Jason A. Castellanos, M. VanSaun, 2016, Oncotarget.

Targeting PI3K Pathway in Pancreatic Ductal Adenocarcinoma: Rationale and Progress

Nagaraj Nagathihalli, S. Mehra, N. Deshpande, 2021, Cancers.

Emerging targets in pancreatic cancer: epithelial–mesenchymal transition and cancer stem cells

N. Merchant, Jason A. Castellanos, Nagaraj Nagathihalli, 2013, OncoTargets and therapy.

CREB activation drives acinar to ductal reprogramming and promote pancreatic cancer progression in animal models of alcoholic chronic pancreatitis

M. VanSaun, Yuguang Ban, J. Datta, 2024, bioRxiv.

Distinct Mechanisms of Innate and Adaptive Immune Regulation Underlie Poor Oncologic Outcomes Associated with KRAS-TP53 Co-Alteration in Pancreatic Cancer

A. Colaprico, N. Merchant, Xiaodian Sun, 2022, bioRxiv.

Inverse Correlation of STAT3 and MEK Signaling Mediates Resistance to RAS Pathway Inhibition in Pancreatic Cancer.

N. Merchant, Jason A. Castellanos, M. VanSaun, 2018, Cancer research.

Novel mechanistic insights into ectodomain shedding of EGFR Ligands Amphiregulin and TGF-α: impact on gastrointestinal cancers driven by secondary bile acids.

Xi Chen, M. Washington, N. Merchant, 2014, Cancer research.

Combined MEK and STAT3 inhibition reprograms stromal inflammation to overcome immunotherapy resistance in pancreatic cancer

N. Merchant, P. Hosein, Yuguang Ban, 2022, bioRxiv.

Adiponectin receptor agonists inhibit leptin induced pSTAT3 and in vivo pancreatic tumor growth

N. Merchant, Alisha M. Mendonsa, Jason A. Castellanos, 2017, Oncotarget.

Combined Blockade of MEK and CDK4/6 Pathways Induces Senescence to Improve Survival in Pancreatic Ductal Adenocarcinoma

N. Merchant, Jason A. Castellanos, B. Willobee, 2021, Molecular Cancer Therapeutics.

Src kinase inhibition restores E-cadherin expression in dasatinib-sensitive pancreatic cancer cells

N. Merchant, Jason A. Castellanos, M. VanSaun, 2019, Oncotarget.

Interleukin-1 signaling in solid organ malignancies.

N. Merchant, J. Datta, A. Dosch, 2021, Biochimica et biophysica acta. Reviews on cancer.

Src-mediated regulation of E-cadherin and EMT in pancreatic cancer.

N. Merchant, Nagaraj Nagathihalli, Nagaraj S Nagathihalli, 2012, Frontiers in bioscience.

RAD51 as a potential biomarker and therapeutic target for pancreatic cancer.

G. Nagaraju, Nagaraj Nagathihalli, Nagaraj S Nagathihalli, 2011, Biochimica et biophysica acta.

Pancreatic Cancer Stem Cells in Tumor Progression, Metastasis, Epithelial- Mesenchymal Transition and DNA Repair

Nagaraj Nagathihalli, E. Brown, Nagaraj S Nagathihalli, 2013 .

Altered SignaLing Pathways and Potential Therapeutic Targets in Pancreatic Cancer

N. Merchant, Jason A. Castellanos, Nagaraj S Nagathihalli, 2014 .

Increased MTH1-specific 8-oxodGTPase activity is a hallmark of cancer in colon, lung and pancreatic tissue.

E. Kool, D. Nguyen, N. Merchant, 2019, DNA repair.

Optical Imaging of Drug-Induced Metabolism Changes in Murine and Human Pancreatic Cancer Organoids Reveals Heterogeneous Drug Response

Alex J. Walsh, N. Merchant, Jason A. Castellanos, 2015, Pancreas.